Загрузка...
Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study
INTRODUCTION: Latanoprostene bunod (LBN) is a novel nitric oxide (NO)-donating prostaglandin F2α analog. We evaluated the long-term safety and intraocular pressure (IOP)-lowering efficacy of LBN ophthalmic solution 0.024% over 1 year in Japanese subjects with open-angle glaucoma (OAG) or ocular hype...
Сохранить в:
| Опубликовано в: : | Adv Ther |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Healthcare
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5020123/ https://ncbi.nlm.nih.gov/pubmed/27457469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-016-0385-7 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|